OUR STORY

 

This is the most critical time in history for the global drug discovery and development community to come together. Evident with every viral pandemic including COVID-19, rapid deployment of compatible antiviral therapies is of paramount importance, particularly as new viral variants occur that could still evade vaccines.


Antivirals can prevent or control viral diseases from emerging diseases, respiratory infections, chronic diseases to virus-associated tumours.


Join us at the congress to get up to speed and help accelerate your antiviral research from bench to patient.


With hundreds of potential customers in attendance there will be opportunities to meet & network with contacts who are looking for solutions to commercial and scientific challenges in:

● Manufacturing

● clinical trials

● Influenza

● Retrovirus

● antiviral therapies and much more.


We will identify the urgent priorities for research, to mobilize, coordinate and align funding to enable the research needed to tackle this crisis. Join us to learn mechanisms for continuing scientific interactions and collaborations, now and beyond the congress.

KEY THEMES

 

INFLUENZA

 

CLINICAL TRIALS

 

COVID & EMERGING VIRUS

 

REGULATORY

RETROVIRUS

 

MANUFACTURING

 

FUNDING

 

ANTIVIRAL THERAPY

 

 

Hundreds of Speakers
World leading Keynotes
Partnering Meeting System
Exhibition Showcases
Interactive Roundtables
Peer to Peer Networking
Evening Receptions
Hundreds of Attendees
Start-Up Zone
 

 

 

For sponsorship opportunities

Thomas Hall
thomas.hall@terrapinn.com

For speaking opportunities

Lauren Sheppard
lauren.sheppard@terrapinn.com

Co-located with:

World Vaccine & Immunotherapy Congress West Coast